Mohammad Abbas, MD
Pain Medicine · Leesburg, FLNPI 1669826921
Payments from drug & device makers
Across 40 payments — averaging $123.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$3K
- Pinnacle, Inc$1K
- Abbott$585
- AbbVie$244
- Boston Scientific$105
- AstraZeneca$21
- plus $15 from 1 others
What the payments were for
- Grants$1,75436%
- Travel & lodging$1733%
- Food & beverage$1,81137%
- Education$1,20024%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 21 | $2,761 |
| Pinnacle, Inc | 2 | $1,206 |
| Abbott | 7 | $585 |
| AbbVie(2 entities) | 5 | $244 |
| Boston Scientific | 3 | $105 |
| AstraZeneca | 1 | $21 |
| Teva Pharmaceuticals USA, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SYNCHROMEDII$1,754
- INTELLIS ADAPTIVESTIM$300
- INCEPTIV$158
- KYPHON EXPRESS II KYPHOPAK TRAY$152
- Proclaim IPG$146
- PRODIGY$146
- PROCLAIM$122
- UBRELVY$104
How this compares
$4,937 in reported general payments places this provider in the 65th percentile of 596 pain medicine providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Pregabalin | 541 | $22,266 |
| Gabapentin | 326 | $10,634 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 519 | $9,337 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 192 | $3,880 |
| Lidocaine | 39 | $3,450 |
| Tizanidine Hcl | 170 | $1,234 |
| Tramadol Hcl | 193 | $1,157 |
| Tramadol Hcl ErTramadol Hcl | 17 | $1,031 |
| Naloxone Hcl | 11 | $976 |
| Methylprednisolone | 112 | $859 |
| Baclofen | 29 | $704 |
| Duloxetine Hcl | 48 | $696 |
| Nortriptyline Hcl | 62 | $663 |
| Methocarbamol | 35 | $520 |
| Cyclobenzaprine Hcl | 34 | $300 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Leesburg
- Anand PatelOrmond Beach$20.4M
- Julio PaezClermont$2.3M
- Joseph PergolizziNaples$2.1M
- Abel MurilloMiami$1.6M
- George MonluxPalm Coast$1.3M
- Ferdinand FormosoJacksonville$1M
- Cesar LassalleOrlando$1M
- Robert GuirguisTampa$895K
- Ashraf HannaClearwater$608K
- Peter MichaelCoral Gables$496K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.